Original language | English |
---|---|
Pages (from-to) | E6 |
Journal | International Journal of Cancer |
Volume | 135 |
Issue number | 7 |
DOIs |
|
State | Published - 1 Oct 2014 |
Erratum: MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer. Int J Cancer. 2014 May 15;134(10):2424-2436 doi: 10.1002/ijc.28566. Epub 2013 Nov 23.
Y. J. Kim, H. S. Choi, J. Seo, J. Y. Song, S. E. Lee, M. J. Kwon, M. J. Kwon, J. Kundu, K. Jung, E. Oh, Y. K. Shin, Y. L. Choi
Research output: Contribution to journal › Comment/debate